| The $6 Billion Bet on What Could Be Oncology's Next Big Breakthrough |
|
| This is what staying ahead looks like. Pay up early, take the risk, and lock in the upside before the data is fully proven.
If it works, this won't look expensive. It will look well-timed. Read on for everything you need to know. |
|
| | | | Energy | Dominion Energy Flips the Switch on a New Power Era | | Dominion Energy, Inc. (NYSE: D) has started delivering electricity from its Coastal Virginia Offshore Wind project, marking the transition from construction to actual power generation. This is the largest offshore wind project in the U.S., and it is now officially doing what it was built to do. | That shift matters more than any announcement. When you move from building to producing, the project stops being a cost center and starts becoming part of the company's energy output. | Scale Starts to Show Up | The project is massive, 176 turbines and 2.6 gigawatts of capacity, with enough output expected to power hundreds of thousands of homes once complete. More importantly, it is already feeding electricity into the grid while still under construction. | This kind of phased ramp-up gives Dominion earlier returns on a long-cycle investment. You can see how that changes the timeline from waiting years for a payoff to gradually building it in. | Execution Becomes the Story | With more than half the project already built and installation continuing, Dominion is proving it can execute at scale in a category that has challenged many developers. | If execution continues, this project becomes a template, not a one-off, and you are watching Dominion turn renewable ambition into real, bankable power. | D currently trades at $61 and pays a dividend of $2.67 per share, a yield of 4.36%. |
|
| | Telecommunications | Comcast Quietly Upgrades the Internet Under Your Feet | | Comcast Corporation (NASDAQ: CMCSA) has expanded its next-generation DOCSIS 4.0 network to millions of homes, moving beyond limited test markets into a broader rollout. What started as a small upgrade is now becoming a core part of its national network. | This matters because scale changes everything. When you go from select cities to millions of homes, you are no longer testing; you are committing. | Building for What Comes Next | Comcast is also preparing its network for future demand, especially as data usage keeps rising and new services like AI and cloud applications grow. The upgraded system can handle changing traffic patterns without constant rebuilds. | This gives Comcast flexibility. Your internet usage today looks very different from a few years ago, and the company is making sure its network can keep up without falling behind. | A Quiet but Important Shift | This is not a flashy launch or a new product. It is a steady upgrade that strengthens Comcast's core business where it matters most, the network itself. | Over time, this kind of investment becomes a real advantage. If the network performs better and scales faster, Comcast stays competitive without needing to constantly chase new offerings. | CMCSA currently trades at $28 and pays a dividend of $1.32 per share, a yield of 4.61%. |
|
| | | | Pharmaceuticals | Pfizer Finds Another Way to Extend Its Cancer Franchise | | Pfizer Inc. (NYSE: PFE) has reported strong late-stage results for one of its cancer drugs, opening the door to its use in a broader patient population. This is not about launching something new; it is about getting more value out of something the company already has. | That matters more than it sounds. When you expand how a drug can be used, you extend its lifespan and its earning power without starting from scratch. | Scaling What Already Works | Instead of chasing entirely new breakthroughs, Pfizer is doubling down on proven products and finding ways to use them earlier and more broadly. This approach is faster, less risky, and easier to execute at scale. | You are seeing a company that is becoming more practical with its pipeline. Rather than betting everything on new discoveries, it is building growth step by step from existing assets. | A Smarter Way to Grow | If approved, this move strengthens Pfizer's position in cancer treatments without needing a brand-new blockbuster. It also shows the company can still compete by improving and expanding what it already sells. | This is where your perspective shifts. Growth is not always about new launches; sometimes it is about making your current products do more work. | PFE currently trades at $27 and pays a dividend of $1.72 per share, a yield of 6.29%. |
|
| | Dividend Stocks Worth Watching | The Coco-Cola Company (NYSE: KO) is doubling down on one of its fastest-growing bets, investing $650M to expand production for its Fairlife brand as demand for higher-protein, lower-sugar dairy continues to climb. | The company is pouring the investment into its Michigan facility, adding new production capacity to keep pace with surging consumer interest in nutrition-focused products. | With additional investments planned across multiple sites and a clear pipeline of innovation, Coca-Cola is positioning Fairlife as a long-term pillar within its portfolio, one that brings the company closer to evolving consumer preferences. | For investors, the story is about smart reinvention. As legacy soda growth matures, scaling brands like Fairlife offers a path to stronger, more diversified revenue streams and the kind of sustained demand that can support Coca-Cola's long-term cash flow and dividend strength. KO pays a 53-cent dividend, yielding 2.82%. | Corebridge Financial, Inc. (NYSE: CRBG) and Equitable Holdings, Inc. (NYSE: EQH) are merging in an all-stock deal that creates a $22 billion financial powerhouse spanning retirement, life insurance, wealth, and asset management. | The combined business will serve over 12 million customers and oversee roughly $1.5 trillion in assets, with scale, distribution, and diversification at the heart of the story. This is about building a more balanced earnings engine, blending fees, spreads, and underwriting into something designed to hold up across cycles. | The pitch is straightforward. Bigger platform, stronger balance sheet, and more consistent cash generation. Management is pointing to immediate earnings accretion, rising to over 10% by 2028, alongside more than $500 million in cost synergies. | Underneath that, there's a strategic shift taking shape. More cross-selling, deeper asset management integration through AllianceBernstein, and a push to modernise distribution and technology. If it lands, this becomes less about two legacy insurers combining and more about building a scaled financial services platform that can compete across multiple fronts. CRBG pays a 25-cent dividend, yielding 4.12% while EQH pays a 27-cent dividend, yielding 2.81%. | Merck & Co., Inc. (NYHSE: MRK) is making a clear move to deepen its oncology pipeline, agreeing to acquire biotech firm Terns Pharmaceuticals, Inc. (NYSE: TERN) for $53 per share in cash, valuing the deal at around $6.7 billion. | This is a targeted bet. The focus is TERN-701, an early-stage but promising treatment for chronic myeloid leukemia that could emerge as a best-in-class option if clinical momentum holds. It's still in Phase 1/2, but early data and orphan drug status have been enough to justify a meaningful premium. | Strategically, this fits a familiar playbook. Strengthen the pipeline, diversify beyond existing oncology assets, and secure future growth before assets become fully priced. There's a near-term hit, with a $5.8 billion charge expected, but that's the cost of staying competitive in a space where the next wave of treatments defines long-term value. | If TERN-701 delivers, this becomes a classic case of paying up early to secure a potentially high-impact asset. MRK pays a 85-cent quarterly dividend, yielding 2.84%. | | Dividend Increases | | | TNET has increased its dividend to 29 cents, up 5.45%. Its new yield is 3.14%. | OXM has lifted its dividend to 70 cents, an uptick of 1.45%. Its new yield is 8.76%. | BKU has raised its dividend to 33 cents, a growth of 6.45%. Its new yield is 2.94%. | DOO has increased its dividend to 25 cents, a growth of 257.14%. Its new yield is 1.49%. |
| |
|
| Dividend Decreases | | | | | CNH has cut its dividend to 10 cents, a 60.00% decline. Its new yield is 0.89%. |
| |
| | |
| | Expert Help (Sponsored) | | | Some investors overlook deductions that may help minimize capital gains tax.
These may include eligible investment expenses, cost basis adjustments, and selling costs tied to property.
Each comes with specific IRS definitions and reporting requirements.
That's why many investors seek help from fiduciary financial advisors when planning tax strategies.
See advisor matches. |
|
| | Poll: Which of these feels most "unlimited" until it suddenly isn't? | | | Upcoming Dividend Payers | UNP's ex-dividend date for the forthcoming $1.38 payment is 03/31/26. | PEP's ex-dividend date for the forthcoming $1.42 payment is 03/31/26. | GLAD's ex-dividend date for the forthcoming 15-cent payment is 03/31/26. | PLD's ex-dividend date for the forthcoming $1.07 payment is 03/31/26. | WU's ex-dividend date for the forthcoming 23-cent payment is 03/31/26. | | Everything Else | Apple will add Bosch, Cirrus Logic, and Qnity Electronics to its American Manufacturing Program as it strives to expand its US-based component production. Bank of Montreal is targeting a more than 15% return on equity within the next two years as it focuses on growing its wealth management and U.S. businesses. A jury has found Meta and Google guilty of designing social media platforms that put young people at risk in a landmark social media addiction trial, potentially opening the door for thousands of other cases. Private Equity Firm KKR will invest around $2 billion to acquire the bakery business Nothing Bundt Cakes from the owner of Dunkin Donuts.
|
|
| | That's all for today's edition of the Dividend Brief.
Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!
—Noah Zelvis
DividendBrief.com |
|
